Serum testosterone and prostate cancer in men with germline BRCA1/2 pathogenic variants

OBJECTIVES: The relation of serum androgens and the development of prostate cancer (PCa) is subject of debate. Lower total testosterone (TT) levels have been associated with increased PCa detection and worse pathological features after treatment. However, data from the Reduction by Dutasteride of Pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Dias, Alexander, Brook, Mark N., Bancroft, Elizabeth K., Page, Elizabeth C., Chamberlain, Anthony, Saya, Sibel, Amin, Jan, Mikropoulos, Christos, Taylor, Natalie, Myhill, Kathryn, Thomas, Sarah, Saunders, Edward, Dadaev, Tokhir, Leongamornlert, Daniel, Dyrsø Jensen, Thomas, Evans, D. Gareth, Cybulski, Cezary, Liljegren, Annelie, Teo, Soo H., Side, Lucy, Kote‐Jarai, Zsofia, Eeles, Rosalind A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071088/
https://www.ncbi.nlm.nih.gov/pubmed/37025481
http://dx.doi.org/10.1002/bco2.156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071088/
https://www.ncbi.nlm.nih.gov/pubmed/37025481
http://dx.doi.org/10.1002/bco2.156

Ejemplares similares